Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Lagunita
AddedFeb 13, 2024
UpdatedJun 28, 2026
Lagunita

Lagunita

Operating

Lagunita Biosciences: Investing in and incubating early-stage healthcare companies for impactful clinical solutions.

Location
Menlo Park, CA, US
Founded
2015
Firm
Compare
Portfolio
Employees
Website

Lagunita Biosciences is a healthcare investment company and incubator focused on creating and growing early-stage companies that address significant clinical needs. They partner with scientist entrepreneurs in fields such as ophthalmology, oncology, drug discovery, medical devices, and digital health. Lagunita typically invests in Series A, B, and C rounds, supporting companies through various stages of growth.

Notable portfolio companies include Verana Health, which has raised $37.8 million, and ViewPoint Therapeutics, with $39 million raised. Lagunita's investment philosophy centers on commercializing impactful translational science. They offer unique value-add services by partnering closely with entrepreneurs to found and nurture companies. Key decision-makers at Lagunita bring extensive expertise in healthcare and biotech, ensuring robust support for their portfolio companies.

Lagunita - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments4
Current Portfolio Count1
Total Portfolio Exits1

Top Investment Stages

Series B2 (50.0%)
Series A1 (25.0%)
Series C1 (25.0%)

Stage Mix

Series B 50%Series A 25%Series C 25%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Verana Health logo

Verana Health

ViewPoint Therapeutics logo

ViewPoint Therapeutics

Lagunita - Similar Investment Firms

BioInnovation logo

BioInnovation

Alta Partners logo

Alta Partners

altapartners.com

LifeSci Venture Partners logo

LifeSci Venture Partners

lifesciventure.com

Illumina Ventures logo

Illumina Ventures

Longitude Capital logo

Longitude Capital

Endpoint Ventures logo

Endpoint Ventures

endpoint.vc

venBio Partners logo

venBio Partners

venbio.com

Biomatics Capital Partners logo

Biomatics Capital Partners

Mission BioCapital logo

Mission BioCapital

Bionovus Innovations logo

Bionovus Innovations

Ensemble Labs logo

Ensemble Labs

ensemblelabs.com

Acorn Bioventures logo

Acorn Bioventures

Flagship Pioneering logo

Flagship Pioneering

Wireframe Ventures logo

Wireframe Ventures

wireframevc.com

Vye Ventures logo

Vye Ventures

Lagunita - Classification

Also Known As
  • Lagunita Biosciences, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end